SCARLETRED Presents Results of a New Rosacea Study at the 31st EADV Congress in Milan, Italy
DE
EN

SCARLETRED Presents Results of a New Rosacea Study at the 31st EADV Congress in Milan, Italy

Author

SCARLETRED visits the hybrid EADV congress in Milan from September 7-9, 2022, to present the results of a new rosacea study that used Scarletred®Vision to measure the effectiveness of a new treatment.

SCARLETRED will attend the European Academy of Dermatology and Venereology (EADV) hybrid congress in Milan from September 7-9, 2022, a conference for outstanding scientific exchange in the field of dermatology and venereology. The topics include skin cancer, dermatology and artificial intelligence, and rosacea. The latter will be a topic for SCARLETRED to present the results of a new rosacea study that used Scarletred®Vision to measure the effectiveness of a new treatment. In this study, patients with rosacea received treatment, and the progression was analyzed and quantified with the software.

Stay tuned for more information about the scientific publication and the EADV congress 2022.

Keywords:Certified, CE class 1m medical device, ISO13485
Download PDF

Like the article? Spread the word

linkedin-icon

Related Applications

Related Events

Events

31st EADV Congress 2022 in Milan

September 7, 2022
Milan, Italy

SCARLETRED is presenting results of a new rosacea study that used Scarletred®Vision at the hybrid congress in Milan.

Find out more